ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


HUSH supports application for feasibility study of the drug Eculizumab

5th October 2014

HUSH has supported an application for a feasibility study of the drug Eculizumab, for HUS sufferers.

The drug is currently being successfully used for sufferers of a similar illness called aHUS.

This application is supported by medical and public health experts who believe that this drug could be helpful for sufferers of HUS.

The funding application for this study to the National Institute of Health Research is at a very early stage of the process.

The application is lead by Dr Sally Johnson a Consultant Paediatric Nephrologist at Great North Children's Hospital Newcastle and is supported by Paediatric Nephrologists in England, Wales & Scotland.

If the feasibility application & study is successful it is hoped that a trial of the drug will be carried out on HUS sufferers.




Page
1 of 48
Next > Last >>

5th July 2024

Confirmed cases rise again to 288 in STEC O145 outbreak (Shiga toxin-producing Escherichia coli) from what is thought to have been caused from salad leaves (lettuce) in sandwiches and wraps. ... ...read on
27th June 2024

The UK Health Security Agency (UKHSA) stated in their press release of today 27... ...read on
21st June 2024

According to an update yesterday the 20th June 2024 from the  UK Health Security Agency (UKHSA) ,the number of confirmed ... ...read on
14th June 2024

Two suppliers of Supermarket sandwiches and wraps recall products as a precaution after E.coli O145 (Shiga toxin-producing Escherichia coli often referred to as ... ...read on
6th June 2024

The UK Health Security Agency (UKHSA) has advised of a large outbreak of Shiga toxin-producing Escherichia coli (STEC) O145, that currently appears to be spreading across the UK. This follow... ...read on
Page
1 of 48
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy